Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis.
Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
19 authors.
Giulia PaolaniDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0002-7403-2414
Silvia MinosseU.O.C Diagnostic Imaging, Department of Integrated Care Processes, Fondazione PTV Policlinico "Tor Vergata", University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.ORCID 0000-0002-9921-6287
Silvia StrolinDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Miriam SantoroDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0002-7751-868X
Noemi PucciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
Francesca Di GiulianoDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
Francesco GaraciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
Letizia OddoDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0000-0002-1883-6821
Yosra ToumiaDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0000-0001-7604-3144
Eugenia GuidaDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
Francesco RiccitelliDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.
Giulia PerilliDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0009-0000-9900-0606
Alessandra VitalitiDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0000-0001-9394-8674
Angelico BediniDepartment of Technological Innovations and Safety of Plants, Products and Anthropic Settlements (DIT), Italian National Institute for Insurance against Accidents at Work, Inail, Piazzale Giulio Pastore 6, 00144 Rome, Italy.
Susanna DolciDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.ORCID 0000-0002-6864-3673
Gaio ParadossiDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0000-0003-3051-3811
Fabio DomeniciDepartment of Chemical Science and Technologies, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy.ORCID 0000-0001-6776-2737
Valerio Da RosDepartment of Biomedicine and Prevention, University of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.ORCID 0000-0001-7167-7594
Lidia StrigariDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0003-4293-2298
Funding
Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro BRIC 2022 ID 53
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Intra-Arterial Super-Selective Delivery of Yttrium-90 for the Treatment of Recurrent Glioblastoma: In Silico Proof of Concept with Feasibility and Safety Analysis. · full record | OpenQuestion